Infectious Disease Travel Medicine Emergency Medicine A
WHO Severe Malaria Criteria
WHO 2015 criteria for severe P. falciparum malaria requiring parenteral artesunate and ITU-level care.
References
- WHO. Severe malaria. Trop Med Int Health. 2014;19 Suppl 1:7-131.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Quinine · Antimalarial — Severe / Complicated Malaria (IV) / Nocturnal Cramps (Oral)
- Tezepelumab (CRSwNP / Severe Asthma) · Anti-TSLP (Thymic Stromal Lymphopoietin) Monoclonal Antibody
- Prednisolone (Oral — General Medicine) · Oral Corticosteroid
- Atovaquone · Antiparasitic / Antifungal — PCP Prophylaxis / Treatment / Malaria
- Hydroxychloroquine · Aminoquinoline — Malaria Prophylaxis / SLE / Rheumatoid Arthritis
- Artesunate · Artemisinin Derivative Antimalarial
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Isoniazid (INH) overdose · TOXBASE/NPIS; AACT/EAPCCT; BNF
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.